Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study

Name: Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study
Published: 2019
License: Public Domain

Novartis Pharmaceuticals · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

migraine monoclonalantibody

migraine, migraine disorders, migraine headache, episodic migraine, chronic migraine, headache, erenumab, amg334, aimovig, monoclonal antibody, cgrp-receptor antibody, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study

Related documents